With the overnight share issue at a premium of 7.65 (up from 5.25) and pre-market on 8/2/21 at 8.9 the hopium on the higher time frames may not seem so far fetched. Ocugen may be the dark horse to win the Covid-19 vaccine race.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
